Back to Search
Start Over
Vector-based SARS-CoV-2 vaccination is associated with improved T-cell responses in hematological neoplasia
- Source :
- Blood Advances; July 2023, Vol. 7 Issue: 14 p3403-3415, 13p
- Publication Year :
- 2023
-
Abstract
- •Vector-based SARS-CoV-2 vaccines are advantageous for the generation of T-cell responses in patients with hematological neoplasia.•CD4+and CD8+T-cell responses cooccur in hematological neoplasms, whereas IgG titers are CD4+T cells associated in myeloid neoplasia only.
Details
- Language :
- English
- ISSN :
- 24739529 and 24739537
- Volume :
- 7
- Issue :
- 14
- Database :
- Supplemental Index
- Journal :
- Blood Advances
- Publication Type :
- Periodical
- Accession number :
- ejs62679608
- Full Text :
- https://doi.org/10.1182/bloodadvances.2022009054